Showing results (11-20 of 796) with videos related to
Sort By:
Pageof 80
Diabetes & Metabolism|July 22, 2008
Beta-cell apoptosis in type 2 diabetes: quantitative and functional consequencesR Lupi, S Del PratoDiabetes Research and Clinical Practice|August 1, 1995
What therapy do our NIDDM patients need? Insulin releasersG Crepaldi, S Del PratoDiabetes Technology & Therapeutics|January 5, 2005
Targeting insulin resistance and beta-cell dysfunction: the role of thiazolidinedionesS Del Prato, P MarchettiHormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|January 19, 2005
Beta- and alpha-cell dysfunction in type 2 diabetesS Del Prato, P MarchettiNutrition, Metabolism, and Cardiovascular Diseases : NMCD|April 24, 2016
Dipeptidyl peptidase-4 inhibition in chronic kidney disease and potential for protection against diabetes-related renal injuryG Penno, M Garofolo, S Del PratoInternational Journal of Clinical Practice. Supplement|December 6, 2007
We have the evidence, we need to act to improve diabetes careS Del Prato, E Horton, R Nesto, et al.Acta Diabetologica|April 12, 2003
Six-month efficacy of benfluorex vs. placebo or metformin in diet-failed type 2 diabetic patientsS Del Prato, D W Erkelens, M LeuteneggerDiabetes, Obesity & Metabolism|November 9, 2013
Efficacy and safety of vildagliptin in patients with type 2 diabetes mellitus inadequately controlled with dual combination of metformin and sulphonylureaV Lukashevich, S Del Prato, M Araga, et al.Diabetes & Metabolism|September 23, 2003
Reducing insulin resistance with metformin: the evidence todayR Giannarelli, M Aragona, A Coppelli, et al.Diabetes|February 1, 1995
Bedtime insulin/daytime glipizide. Effective therapy for sulfonylurea failures in NIDDMM L Shank, S Del Prato, R A DeFronzoPageof 80